Status:
COMPLETED
Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Pulmonary Disease, Chronic Obstructive
Infections, Bacterial
Eligibility:
All Genders
40+ years
Brief Summary
The aim of the study is to develop a new patient-reported outcome (PRO) questionnaire measuring the impact of an acute exacerbation on daily lives of patients with chronic obstructive pulmonary diseas...
Eligibility Criteria
Inclusion
- 15 pack-year smoking history.
- Confirmed diagnosis of COPD.
- Have two documented episodes of acute exacerbation in past 12 months.
Exclusion
- Clinical diagnosis of asthma.
- Subjects not literate in the language of the questionnaire (e.g. US English).
Key Trial Info
Start Date :
November 2 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2006
Estimated Enrollment :
259 Patients enrolled
Trial Details
Trial ID
NCT00259909
Start Date
November 2 2005
End Date
November 7 2006
Last Update
October 12 2017
Active Locations (123)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Birmingham, Alabama, United States, 35209
2
GSK Investigational Site
Birmingham, Alabama, United States, 35233
3
GSK Investigational Site
Birmingham, Alabama, United States, 35294
4
GSK Investigational Site
Hueytown, Alabama, United States, 35023